288 related articles for article (PubMed ID: 17616751)
1. Involvement of endogenous nitric oxide in angiotensin II-induced activation of vascular mitogen-activated protein kinases.
Zhang GX; Nagai Y; Nakagawa T; Miyanaka H; Fujisawa Y; Nishiyama A; Izuishi K; Ohmori K; Kimura S
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2403-8. PubMed ID: 17616751
[TBL] [Abstract][Full Text] [Related]
2. Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells.
Kyaw M; Yoshizumi M; Tsuchiya K; Kirima K; Tamaki T
Hypertens Res; 2001 May; 24(3):251-61. PubMed ID: 11409648
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria-derived reactive oxygen species and vascular MAP kinases: comparison of angiotensin II and diazoxide.
Kimura S; Zhang GX; Nishiyama A; Shokoji T; Yao L; Fan YY; Rahman M; Abe Y
Hypertension; 2005 Mar; 45(3):438-44. PubMed ID: 15699441
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II inhibits neuronal nitric oxide synthase activation through the ERK1/2-RSK signaling pathway to modulate central control of blood pressure.
Cheng WH; Lu PJ; Ho WY; Tung CS; Cheng PW; Hsiao M; Tseng CJ
Circ Res; 2010 Mar; 106(4):788-95. PubMed ID: 20056918
[TBL] [Abstract][Full Text] [Related]
5. Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells.
Yoshizumi M; Tsuchiya K; Kirima K; Kyaw M; Suzaki Y; Tamaki T
Mol Pharmacol; 2001 Oct; 60(4):656-65. PubMed ID: 11562426
[TBL] [Abstract][Full Text] [Related]
6. Loss of biphasic effect on Na/K-ATPase activity by angiotensin II involves defective angiotensin type 1 receptor-nitric oxide signaling.
Banday AA; Lokhandwala MF
Hypertension; 2008 Dec; 52(6):1099-105. PubMed ID: 18955661
[TBL] [Abstract][Full Text] [Related]
7. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species.
Viedt C; Soto U; Krieger-Brauer HI; Fei J; Elsing C; Kübler W; Kreuzer J
Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):940-8. PubMed ID: 10764657
[TBL] [Abstract][Full Text] [Related]
8. p38 mitogen-activated protein kinase contributes to angiotensin II-stimulated migration of rat aortic smooth muscle cells.
Lee HM; Lee CK; Lee SH; Roh HY; Bae YM; Lee KY; Lim J; Park PJ; Park TK; Lee YL; Won KJ; Kim B
J Pharmacol Sci; 2007 Sep; 105(1):74-81. PubMed ID: 17895590
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway.
Bouallegue A; Daou GB; Srivastava AK
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2072-9. PubMed ID: 17644565
[TBL] [Abstract][Full Text] [Related]
10. Myoglobin facilitates angiotensin II-induced constriction of renal afferent arterioles.
Liu ZZ; Mathia S; Pahlitzsch T; Wennysia IC; Persson PB; Lai EY; Högner A; Xu MZ; Schubert R; Rosenberger C; Patzak A
Am J Physiol Renal Physiol; 2017 May; 312(5):F908-F916. PubMed ID: 28052871
[TBL] [Abstract][Full Text] [Related]
11. Vessel-specific stimulation of protein synthesis by nitric oxide synthase inhibition: role of extracellular signal-regulated kinases 1/2.
Martens FM; Demeilliers B; Girardot D; Daigle C; Dao HH; deBlois D; Moreau P
Hypertension; 2002 Jan; 39(1):16-21. PubMed ID: 11799072
[TBL] [Abstract][Full Text] [Related]
12. ROS during the acute phase of Ang II hypertension participates in cardiovascular MAPK activation but not vasoconstriction.
Zhang GX; Kimura S; Nishiyama A; Shokoji T; Rahman M; Abe Y
Hypertension; 2004 Jan; 43(1):117-24. PubMed ID: 14638624
[TBL] [Abstract][Full Text] [Related]
13. A role for PYK2 in regulation of ERK1/2 MAP kinases and PI 3-kinase by ANG II in vascular smooth muscle.
Rocic P; Govindarajan G; Sabri A; Lucchesi PA
Am J Physiol Cell Physiol; 2001 Jan; 280(1):C90-9. PubMed ID: 11121380
[TBL] [Abstract][Full Text] [Related]
14. p38 MAP kinase pathway regulates angiotensin II-induced contraction of rat vascular smooth muscle.
Meloche S; Landry J; Huot J; Houle F; Marceau F; Giasson E
Am J Physiol Heart Circ Physiol; 2000 Aug; 279(2):H741-51. PubMed ID: 10924074
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant effect of adrenomedullin on angiotensin II-induced reactive oxygen species generation in vascular smooth muscle cells.
Yoshimoto T; Fukai N; Sato R; Sugiyama T; Ozawa N; Shichiri M; Hirata Y
Endocrinology; 2004 Jul; 145(7):3331-7. PubMed ID: 15070851
[TBL] [Abstract][Full Text] [Related]
16. Role of neuronal NO synthase in regulating vascular superoxide levels and mitogen-activated protein kinase phosphorylation.
Zhang GX; Kimura S; Murao K; Shimizu J; Matsuyoshi H; Takaki M
Cardiovasc Res; 2009 Feb; 81(2):389-99. PubMed ID: 18987049
[TBL] [Abstract][Full Text] [Related]
17. Superoxide anion mediates angiotensin II-induced potentiation of contractile response to sympathetic stimulation.
Lu C; Su LY; Lee RM; Gao YJ
Eur J Pharmacol; 2008 Jul; 589(1-3):188-93. PubMed ID: 18538762
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide-mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinase.
Jadeski LC; Chakraborty C; Lala PK
Int J Cancer; 2003 Sep; 106(4):496-504. PubMed ID: 12845643
[TBL] [Abstract][Full Text] [Related]
19. Dissociation of angiotensin II-stimulated activation of mitogen-activated protein kinase kinase from vascular contraction.
Watts SW; Florian JA; Monroe KM
J Pharmacol Exp Ther; 1998 Sep; 286(3):1431-8. PubMed ID: 9732408
[TBL] [Abstract][Full Text] [Related]
20. Roles of nitric oxide and oxidative stress in the regulation of blood pressure and renal function in prehypertensive Ren-2 transgenic rats.
Vanecková I; Kramer HJ; Novotná J; Kazdová L; Opocenský M; Bader M; Ganten D; Cervenka L
Kidney Blood Press Res; 2005; 28(2):117-26. PubMed ID: 15795515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
